Search

Author/Creator Komocsar, Wendy J.

1. Efficacy and Safety of Tabalumab, an Anti–B-Cell–Activating Factor Monoclonal Antibody, in a Heterogeneous Rheumatoid Arthritis Population. Issue 5 (August 2015)

Authors:
Genovese, Mark C.; Silverman, Gregg J.; Emery, Paul; Gupta, Ramesh C.; Gill, Anne; Veenhuizen, Melissa; Xie, Li; Komocsar, Wendy J.; Berclaz, Pierre-Yves; Lee, Chin
Journal:
Journal of clinical rheumatology
Issue:
Volume 21:Issue 5(2015:Aug.)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy and Safety of Tabalumab, an Anti–B-Cell–Activating Factor Monoclonal Antibody, in a Heterogeneous Rheumatoid Arthritis Population: Results From a Randomized, Placebo-Controlled, Phase 3 Trial (FLEX-O). Issue 5 (August 2015)

Authors:
Genovese, Mark C.; Silverman, Gregg J.; Emery, Paul; Gupta, Ramesh C.; Gill, Anne; Veenhuizen, Melissa; Xie, Li; Komocsar, Wendy J.; Berclaz, Pierre-Yves; Lee, Chin
Journal:
Journal of clinical rheumatology
Issue:
Volume 21:Issue 5(2015:Aug.)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Fully human anti-BAFF inhibitory monoclonal antibody tabalumab does not adversely affect T-dependent antibody responses in cynomolgus monkey (Macaca fasicularis): A summary of three pre-clinical immunotoxicology evaluations. (2nd January 2016)

Authors:
Komocsar, Wendy J.; Blackbourne, Jamie L.; Halstead, Carolyn A.; Winstead, Colleen J.; Wierda, Daniel
Journal:
Journal of immunotoxicology
Issue:
Volume 13:Number 1(2016)
Page Start:
7
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Gene Expression and Pharmacodynamic Changes in 1, 760 Systemic Lupus Erythematosus Patients From Two Phase III Trials of BAFF Blockade With Tabalumab. Issue 3 (27th February 2017)

Authors:
Hoffman, Robert W.; Merrill, Joan T.; Alarcón‐Riquelme, Marta M. E.; Petri, Michelle; Dow, Ernst R.; Nantz, Eric; Nisenbaum, Laura K.; Schroeder, Krista M.; Komocsar, Wendy J.; Perumal, Narayanan B.; Linnik, Matthew D.; Airey, David C.; Liu, Yushi; Rocha, Guilherme V.; Higgs, Richard E.
Journal:
Arthritis & rheumatology
Issue:
Volume 69:Issue 3(2017)
Page Start:
643
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Gene Expression and Pharmacodynamic Changes in 1, 760 Systemic Lupus Erythematosus Patients From Two Phase III Trials of BAFF Blockade With Tabalumab. Issue 3 (March 2017)

Authors:
Hoffman, Robert W.; Merrill, Joan T.; Alarcón‐Riquelme, Marta M. E.; Petri, Michelle; Dow, Ernst R.; Nantz, Eric; Nisenbaum, Laura K.; Schroeder, Krista M.; Komocsar, Wendy J.; Perumal, Narayanan B.; Linnik, Matthew D.; Airey, David C.; Liu, Yushi; Rocha, Guilherme V.; Higgs, Richard E.
Journal:
Arthritis & rheumatology
Issue:
Volume 69:Issue 3(2017)
Page Start:
643
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Treatment and biologic maintenance-dosing patterns among pediatric patients with ulcerative colitis or Crohn's disease. (2nd January 2023)

Authors:
Hunter, Theresa; Komocsar, Wendy J.; Colletti, Richard B.; Liu, Chunyan; Benkov, Keith J.; Dotson, Jennifer L.; Steiner, Steven J.; Zhang, Nanhua; Crandall, Wallace
Journal:
Current medical research and opinion
Issue:
Volume 39:Number 1(2023)
Page Start:
63
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗